HTGM News and Press, HTG Molecular Diagnostics Inc. From 10/31/19

Quick Take Centogene ( OTC:CNTG ) has filed to raise $60 million from the sale of common stock in a U.S. IPO, according to an amended F-1/A registration statement . The company provides genetic insights to researchers and clinicians in various regions worldwide. CNTG is producing accele...

TUCSON, Ariz., Oct. 31, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the third quarter ended September 30, 2019 after the market c...

TUCSON, Ariz., Oct. 22, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) , a diagnostic company whose mission is to advance precision medicine, today announced that it will host a Key Opinion Leader (KOL) luncheon at 12:00 pm ET on Tuesday, October 29 th in New York...

Quick Take Centogene ( OTC:CNTG ) has filed to raise gross proceeds of $69 million from a U.S. IPO, according to an F-1 registration statement . The firm has developed a platform for the identification of rare genetic diseases. CNTG is growing smartly in a favorable industry segment, al...

TUCSON, Ariz., Oct. 15, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it will begin taking orders for its new 2,002-gene HTG EdgeSeq Autoimmune Panel, which is expect...

HTG Molecular Diagnostics (NASDAQ: HTGM ) provides an update regarding its ongoing efforts related to the development, manufacture and commercialization of companion diagnostic assays. More news on: HTG Molecular Diagnostics, Inc., Healthcare stocks news, Read more ...

TUCSON, Ariz., Oct. 10, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today provided an update regarding its ongoing efforts related to the development, manufacture and commercialization of...

The following slide deck was published by HTG Molecular Diagnostics, Inc. in conjunction with this Read more ...

TUCSON, Ariz., Sept. 30, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that John Lubniewski, President and CEO, will present a corporate overview at the Cantor 2019 Global...

TUCSON, Ariz., Sept. 24, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced the completion of its previously announced underwritten public offering of 29,298,537 shares of its co...